StarMed has opened a new monoclonal antibody therapy clinic in Charlotte as the use of treatment in North Carolina has increased 18-fold.

Charlotte, NC (WBTV)-StarMed Healthcare will open a new clinic location in the Charlotte area to be the first non-medical system clinic to offer COVID-19 treatment, a free monoclonal antibody therapy.

The new clinic is located on 491 North Wendover Road. The new space will contain 14 private rooms to accommodate monoclonal antibody patients.

StarMed will continue to work with other counties in the state to establish similar clinics.

StarMed states that its goal is to ease the burden on the hospital system by providing patients with REGEN-COV monoclonal antibody therapy.

• Reduces COVID-19 mortality by 20% -70%.
• Reduces symptoms in COVID-positive patients for 2 weeks.
• It reduces viral load and reduces patient transmission.

For patients exposed to COVID-19, monoclonal antibody therapy can be used as post-exposure prophylaxis, reducing the incidence of symptomatic COVID-19 by 93%.

REGEN-COV is approved by the US Food and Drug Administration (FDA) under an Emergency Use Authorization (EUA).

Due to limited supply, reservations are starmed.care Website.

Monoclonal antibodies are made in the laboratory. They can be administered to patients via IV infusion. It takes about 21 minutes to get treatment. Patients should wait an hour after treatment to monitor for side effects.

REGEN-COV is produced by obtaining innate immunity from covid-positive donors and replicating antibody proteins specific to the fight against COVID-19.

The replicated antibody is administered by either a 21-minute IV injection or a subcutaneous injection, and side effects are observed for 60 minutes. Antibodies remain in the patient’s system for 30-90 days.

Mild side effects include nausea and dizziness, but serious side effects are rare. A complete list of safety and effectiveness can be found on the StarMed website.

Monoclonal antibody therapy is completely free for patients and is not a substitute for the COVID-19 vaccine.

Patients who should receive REGEN-COV monoclonal antibody therapy:

• Individuals over the age of 12 who are not vaccinated can receive monoclonal antibody therapy.
• People who are vaccinated but are immunocompromised due to underlying health conditions such as cancer, organ transplants, autoimmune diseases, and chronic steroid use.
• COVID-19-positive individuals with mild or moderate symptoms.

Patients who should not receive REGEN-COV monoclonal antibody therapy:

• Patients with severe symptoms and those in need of increased oxygen due to COVID-19 positivity.
• People who have been exposed to COVID-19 but have been vaccinated and are able to respond well.

Last week, North Carolina health leaders said Monoclonal antibody for the treatment of COVID-19 It increased 18-fold from 100 doses per week from late June to June 23 to 1,874 doses per week on August 11.

Throughout the state, there are more than 130 sites offering monoclonal antibodies to treat COVID-19. This treatment can reduce the chances of hospitalization associated with COVID-19.

Talk to your healthcare provider Monoclonal antibody therapy Optional, please find Treatment center near you Alternatively, call the Federal Monoclonal Antibody Call Center at 1-877-332-6585 (English) or 1-877-366-0310 (Spanish) for assistance.

Some people may be eligible Prophylactic treatment Before showing symptoms.

More information, including answers to frequently asked questions, is available at COVID-19 on NCDHHS. Website..

The federal government provides patients with monoclonal antibody therapy free of charge. However, your healthcare provider may charge an administration fee for your treatment. Medicare and many commercial insurers cover all costs for patients. Check with your health insurance for more information on treatment costs.

Copyright 2021W BTV. all rights reserved.